About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Technicals
+12 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company News
Shilpa Medicare Ltd
Pharmaceuticals - Indian - Formulations
BSE Code:
530549
NSE Symbol:
SHILPAMED
P/E :
68.81
ISIN Demat:
INE790G01031
Div & Yield %:
0.13
EPS :
5.65
Book Value:
137.47
Market Cap (Rs. Cr.):
7,603.24
Face Value :
1
Date
Headline
24-Feb-26
SteinCares inks strategic licensing agreement with Shilpa Biologicals
13-Feb-26
Shilpa Medicare enters into development and supply agreement with NXI Therapeutics AG
07-Feb-26
Shilpa Medicare submits ANDA for Rotigotine transdermal patch
30-Jan-26
Shilpa Medicare to convene board meeting
12-Dec-25
Shilpa Medicare receives initial authorization from Europe for Rotigotine Transdermal Patch
22-Nov-25
Shilpa Medicare's Unit IV completes USFDA inspection
17-Nov-25
Shilpa Medicare launches NODUCA™ therapy in India
06-Nov-25
Shilpa Medicare to announce Quarterly Result
27-Oct-25
Shilpa Medicare to sell its 31% stake in Sravathi Advance Process Technologies
06-Oct-25
Shilpa Medicare allots 9.77 cr equity shares under bonus issue
Prev
1
2
3
Next